Market Cap 624.74B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 23.66
Forward PE 22.13
Profit Margin 28.46%
Debt to Equity Ratio 0.44
Volume 6,532,100
Avg Vol 8,436,688
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 36%
Beta 0.24
Analysts Strong Sell
Price Target $275.42

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
OnyxQuants
OnyxQuants Aug. 10 at 3:27 PM
$AGQ $DDOG $MP $HPE $JNJ AGQ provides leveraged silver exposure, Datadog benefits from cloud and AI workload growth, MP Materials benefits from strategic-mineral demand, Hewlett Packard Enterprise benefits from AI infrastructure investment, and Johnson & Johnson provides diversified healthcare exposure. I'm watching silver prices, cloud spending, commodity demand, AI capex, and healthcare trends.
0 · Reply
twiggs462
twiggs462 Aug. 10 at 3:20 PM
$JNJ purchased Janssen Pharmaceuticals, eight years after it was originally founded... 2H of 2027 will be eight years since $DFTX was founded... :)
0 · Reply
Matt_1
Matt_1 Aug. 10 at 3:00 PM
$CVRX $GSK $JNJ 😎👍
0 · Reply
theoptionsplug
theoptionsplug Aug. 10 at 2:59 PM
$JNJ forming a beautiful bull flag on the daily chart Current support sits at $255 which if held, targets at $263 then $270! (50DMA brings an additional layer of support at $250)
0 · Reply
Orbit100
Orbit100 Aug. 10 at 2:44 PM
$JNJ Market is showing a great resilience. S&P is predicted more bigt gains ahead. Shorts are in for a big surprise. Heed the warning or lose a great deal amount of money keeping their positions opened.
0 · Reply
Orbit100
Orbit100 Aug. 10 at 2:42 PM
$JNJ More large gain of the market ahead this month.
0 · Reply
Tnitty4371
Tnitty4371 Aug. 10 at 2:24 PM
$AAPL 💎💵💎🎁💎💵🎁 $SPY $TSLA $META $JNJ
0 · Reply
TheUnmaker
TheUnmaker Aug. 10 at 2:08 PM
$TNXP Break $14.15 and we go back over $16 this week. $PFE $SLS $JNJ $GRAL
1 · Reply
La_Parka3
La_Parka3 Aug. 10 at 1:50 PM
$MRNA $PFE $JNJ The mandates of pandemic past continue to haunt the shorts as they still use it as their excuse to explain away why vaccines continue to sell when the mandates had been cancelled completely several years ago.
0 · Reply
Orbit100
Orbit100 Aug. 10 at 1:46 PM
$JNJ Baby powder settlement is scheduled only to pay in 2027 in different amounts. Meanwhile this is a very solid company. It is set up to soar this year. Watch and learn.
0 · Reply
Latest News on JNJ
Johnson & Johnson Transcript: Investor update

Aug 3, 2026, 8:00 AM EDT - 7 days ago

Johnson & Johnson Transcript: Investor update


Inside J&J's Lab to Create a Simpler Robotic Surgery Device

Aug 2, 2026, 8:00 AM EDT - 8 days ago

Inside J&J's Lab to Create a Simpler Robotic Surgery Device


Johnson & Johnson lowers 2026 profit forecast

Jul 29, 2026, 5:38 PM EDT - 11 days ago

Johnson & Johnson lowers 2026 profit forecast


Explainer: Can J&J finally put the talc litigation behind it?

Jul 29, 2026, 12:01 PM EDT - 11 days ago

Explainer: Can J&J finally put the talc litigation behind it?


Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits

Jul 28, 2026, 12:26 PM EDT - 12 days ago

Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits


J&J offers $5.5bn to settle baby powder lawsuits

Jul 28, 2026, 12:31 AM EDT - 13 days ago

J&J offers $5.5bn to settle baby powder lawsuits


DePuy Synthes Acquires Expanding Innovations™

Jul 16, 2026, 8:00 AM EDT - 25 days ago

DePuy Synthes Acquires Expanding Innovations™


Johnson & Johnson Earnings Call Transcript: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 26 days ago

Johnson & Johnson Earnings Call Transcript: Q2 2026


Johnson & Johnson Slides: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 26 days ago

Johnson & Johnson Slides: Q2 2026


Johnson & Johnson Earnings release: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 26 days ago

Johnson & Johnson Earnings release: Q2 2026


Johnson & Johnson Quarterly report: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 26 days ago

Johnson & Johnson Quarterly report: Q2 2026


Johnson & Johnson Hikes Guidance, Stock Falls

Jul 15, 2026, 6:35 AM EDT - 26 days ago

Johnson & Johnson Hikes Guidance, Stock Falls


Johnson & Johnson Bumps Up Guidance as Sales Rise

Jul 15, 2026, 6:33 AM EDT - 26 days ago

Johnson & Johnson Bumps Up Guidance as Sales Rise


Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

Jul 15, 2026, 6:20 AM EDT - 26 days ago

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook


The Big 3: UNH, KO, JNJ

Jul 9, 2026, 1:00 PM EDT - 4 weeks ago

The Big 3: UNH, KO, JNJ

KO UNH


Johnson & Johnson to Buy Firefly Bio for $1 Billion

Jun 8, 2026, 9:01 AM EDT - 2 months ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion


Johnson & Johnson to buy Firefly Bio for $1 billion

Jun 8, 2026, 8:08 AM EDT - 2 months ago

Johnson & Johnson to buy Firefly Bio for $1 billion


OnyxQuants
OnyxQuants Aug. 10 at 3:27 PM
$AGQ $DDOG $MP $HPE $JNJ AGQ provides leveraged silver exposure, Datadog benefits from cloud and AI workload growth, MP Materials benefits from strategic-mineral demand, Hewlett Packard Enterprise benefits from AI infrastructure investment, and Johnson & Johnson provides diversified healthcare exposure. I'm watching silver prices, cloud spending, commodity demand, AI capex, and healthcare trends.
0 · Reply
twiggs462
twiggs462 Aug. 10 at 3:20 PM
$JNJ purchased Janssen Pharmaceuticals, eight years after it was originally founded... 2H of 2027 will be eight years since $DFTX was founded... :)
0 · Reply
Matt_1
Matt_1 Aug. 10 at 3:00 PM
$CVRX $GSK $JNJ 😎👍
0 · Reply
theoptionsplug
theoptionsplug Aug. 10 at 2:59 PM
$JNJ forming a beautiful bull flag on the daily chart Current support sits at $255 which if held, targets at $263 then $270! (50DMA brings an additional layer of support at $250)
0 · Reply
Orbit100
Orbit100 Aug. 10 at 2:44 PM
$JNJ Market is showing a great resilience. S&P is predicted more bigt gains ahead. Shorts are in for a big surprise. Heed the warning or lose a great deal amount of money keeping their positions opened.
0 · Reply
Orbit100
Orbit100 Aug. 10 at 2:42 PM
$JNJ More large gain of the market ahead this month.
0 · Reply
Tnitty4371
Tnitty4371 Aug. 10 at 2:24 PM
$AAPL 💎💵💎🎁💎💵🎁 $SPY $TSLA $META $JNJ
0 · Reply
TheUnmaker
TheUnmaker Aug. 10 at 2:08 PM
$TNXP Break $14.15 and we go back over $16 this week. $PFE $SLS $JNJ $GRAL
1 · Reply
La_Parka3
La_Parka3 Aug. 10 at 1:50 PM
$MRNA $PFE $JNJ The mandates of pandemic past continue to haunt the shorts as they still use it as their excuse to explain away why vaccines continue to sell when the mandates had been cancelled completely several years ago.
0 · Reply
Orbit100
Orbit100 Aug. 10 at 1:46 PM
$JNJ Baby powder settlement is scheduled only to pay in 2027 in different amounts. Meanwhile this is a very solid company. It is set up to soar this year. Watch and learn.
0 · Reply
Orbit100
Orbit100 Aug. 10 at 1:43 PM
$JNJ JNJ will re test $270 this month.
0 · Reply
Tnitty4371
Tnitty4371 Aug. 10 at 12:51 PM
$TEAM 🔪📉🔪📉🎈 $SPY $TSLA $META $JNJ
0 · Reply
Quantumup
Quantumup Aug. 10 at 11:11 AM
H.C. Wainwright⬆️ $IMMX's PT to $25, reiterated Buy and said -- For 2Q26, Immix reported a net loss of $0.18 per share vs. our prior estimate of a net loss of $0.15 per share. $PRTA $JNJ - GMAB AZN ABBV REGN H.C. Wainwright added—R&D and SG&A expenses were $5.3M and $7.1M respectively, vs. our prior estimates of $6.2M and $4.9M. We now project a full-year 2026 net loss of $0.72 per share vs. our prior net loss estimate of $0.62 per share. Immix ended 2Q26 with ~$234.2M in cash—providing an operational runway extending into mid-2027, in our view. After advancing our discounted cash flow (DCF)-based valuation and taking into account ex-U.S. sales from NXC-201, we reiterate our Buy rating and raise our 12-month price target to $25 from the prior $20 per share.
1 · Reply
TheUnmaker
TheUnmaker Aug. 10 at 11:04 AM
$TNXP Its blue skies from here! $PFE $JNJ $SLS
0 · Reply
Outcomes
Outcomes Aug. 10 at 10:58 AM
$NRXP $MRNA $PFE $JNJ $IBRX .....will FDA revisit?? https://x.com/RetsefL/status/2086740203754889720?s=20
1 · Reply
Matt_1
Matt_1 Aug. 10 at 8:29 AM
$CVRX Current Institutional Ownership Percentage 75.27% - Including Johnson & Johnson $JNJ 15.298% & GSK plc $GSK 3.844% https://www.marketbeat.com/stocks/NASDAQ/CVRX/institutional-ownership/
0 · Reply
EclipseCapital
EclipseCapital Aug. 10 at 7:58 AM
$AEHR $BRK.A $JNJ $FLY $LYFT Aehr benefits from semiconductor test-equipment demand, Berkshire Hathaway provides diversified earnings and strong capital allocation, Johnson & Johnson offers diversified healthcare exposure, FLY remains execution-dependent, and Lyft continues expanding its mobility platform. I'm watching semiconductor capex, healthcare demand, travel activity, and ride volumes.
0 · Reply
pnvoss
pnvoss Aug. 10 at 2:29 AM
$BSX what if Bsx $JNJ or $ABT merged or bought out bsx?
2 · Reply
TheUnmaker
TheUnmaker Aug. 10 at 2:00 AM
$TNXP It's going to be a good month for this stock. $PFE $JNJ $SLS
1 · Reply
Outcomes
Outcomes Aug. 9 at 11:58 PM
$IBRX $JNJ $MRNA $NRXP $PFE 🤔🤔🤔🤔🤔🤔 https://x.com/fynnderella1/status/2086103985505603720?s=46
0 · Reply
Outcomes
Outcomes Aug. 9 at 9:44 PM
$MRNA $PFE $JNJ $NRXP $IBRX mRNA BAD. Beware big Pharma Beware Bureaucrats https://x.com/vacsafety/status/2086494652882989257?s=46
2 · Reply
StockNavigator_
StockNavigator_ Aug. 9 at 3:18 PM
How Every Dow Jones Stock Has Performed in 2026 📊 (Part 1) Here are the early leaders so far: $CSCO +57.6% 🟢 $CAT +47.0% 🟢 $TRV +32.5% 🟢 $AMGN +25.6% 🟢 $JNJ +25.3% 🟢 Interesting to see how much strength has come from a mix of tech, industrials, insurance and healthcare rather than just the usual mega-cap names. I’m watching the next group closely for signs of continued momentum or potential rotation. The next setup is already taking shape. Stay connected.
1 · Reply